Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-357
Closed -$8K 383
2022
Q3
$8K Buy
357
+14
+4% +$344 ﹤0.01% 569
2022
Q2
$8K Sell
343
-76
-18% -$1.93K ﹤0.01% 564
2022
Q1
$10K Hold
419
﹤0.01% 520
2021
Q4
$14K Buy
419
+29
+7% +$920 ﹤0.01% 482
2021
Q3
$11K Buy
390
+44
+13% +$1.32K ﹤0.01% 491
2021
Q2
$11K Sell
346
-2
-0.6% -$63 ﹤0.01% 471
2021
Q1
$10K Sell
348
-88
-20% -$2.52K ﹤0.01% 489
2020
Q4
$12K Buy
436
+82
+23% +$2.23K ﹤0.01% 463
2020
Q3
$8K Buy
354
+94
+36% +$2.18K ﹤0.01% 470
2020
Q2
$6K Buy
+260
New +$5.32K ﹤0.01% 500

Other funds holding AXTA

Howe & Rusling's AXTA Position: Q4 2022 in Review

Howe & Rusling sold out of Axalta (AXTA) in Q4 2022, closing a stake of 357 shares — an estimated $8K sold.

Howe & Rusling first reported a position in AXTA in Q2 2020 and held it in 10 quarters. The position peaked at $14K in Q4 2021. 311 funds tracked by Wall St. Rank hold AXTA as of Q4 2022.

  • Howe & Rusling reported no remaining Axalta position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 357 Axalta shares in Q4 2022, an estimated $8K.
  • Howe & Rusling first reported a position in Axalta in Q2 2020 and held it in 10 quarters.
  • Howe & Rusling's Axalta position peaked at $14K in Q4 2021.
  • 311 funds tracked by Wall St. Rank held Axalta as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.